NRx Pharmaceuticals Statistics

Total Valuation

NRXP has a market cap or net worth of $97.45 million. The enterprise value is $90.78 million.

Market Cap	97.45M
Enterprise Value	90.78M

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, after market close.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

NRXP has 33.03 million shares outstanding. The number of shares has increased by 101.06% in one year.

Current Share Class	33.03M
Shares Outstanding	33.03M
Shares Change (YoY)	+101.06%
Shares Change (QoQ)	+30.27%
Owned by Insiders (%)	5.40%
Owned by Institutions (%)	6.71%
Float	24.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	3.92
PS Ratio	79.96
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	74.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.31

Current Ratio	0.31
Quick Ratio	0.28
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-24.13

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-121.85%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	103.62%
Weighted Average Cost of Capital (WACC)	14.76%
Revenue Per Employee	$42,241
Profits Per Employee	-$986,966
Employee Count	29
Asset Turnover	0.15
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.51% in the last 52 weeks. The beta is 1.83, so NRXP's price volatility has been higher than the market average.

Beta (5Y)	1.83
52-Week Price Change	+42.51%
50-Day Moving Average	2.16
200-Day Moving Average	2.50
Relative Strength Index (RSI)	64.95
Average Volume (20 Days)	1,058,231

Short Selling Information

The latest short interest is 3.25 million, so 9.83% of the outstanding shares have been sold short.

Short Interest	3.25M
Short Previous Month	2.51M
Short % of Shares Out	9.83%
Short % of Float	13.40%
Short Ratio (days to cover)	3.57

Income Statement

In the last 12 months, NRXP had revenue of $1.23 million and -$28.62 million in losses. Loss per share was -$1.34.

Revenue	1.23M
Gross Profit	720,000
Operating Income	-16.19M
Pretax Income	-28.62M
Net Income	-28.62M
EBITDA	-16.12M
EBIT	-16.19M
Loss Per Share	-$1.34

Full Income Statement

Balance Sheet

The company has $7.80 million in cash and $631,000 in debt, giving a net cash position of $7.17 million or $0.22 per share.

Cash & Cash Equivalents	7.80M
Total Debt	631,000
Net Cash	7.17M
Net Cash Per Share	$0.22
Equity (Book Value)	-15.94M
Book Value Per Share	-0.50
Working Capital	-19.69M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-14.11M
Capital Expenditures	n/a
Depreciation & Amortization	70,000
Net Borrowing	4.68M
Free Cash Flow	-14.11M
FCF Per Share	-$0.43

Full Cash Flow Statement

Margins

Gross Margin	58.78%
Operating Margin	-1,321.47%
Pretax Margin	-2,336.49%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NRXP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-101.06%
Shareholder Yield	-101.06%
Earnings Yield	-29.22%
FCF Yield	-14.41%

Analyst Forecast

The average price target for NRXP is $38.25, which is 1,196.61% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$38.25
Price Target Difference	1,196.61%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	162.22%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 2, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Apr 2, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

NRXP has an Altman Z-Score of -37.88 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-37.88
Piotroski F-Score	2